Genezen

?? MARK YOUR CALENDAR ?? Chief Technical and Commercial Officer Susan D'Costa will be in San Diego for BioProcess International West from March 18-21. Contact her directly or reach out here: https://lnkd.in/ej5uSuAD #CDMO #viralvectors #genetherapy #biotech #cellandgenetherapy #pharma #precisionmedicine #BPIWest?

??PARTNER SPOTLIGHT ?? In honor of #RareDiseaseDay, we are proud to highlight one of our parent-founded rare disease partners and help raise visibility about rare diseases and their significant impact on individuals and families. Dr. Nicole Henwood founded the non-profit NF2 BioSolutions, and Merlin Therapeutics, a for-profit therapeutic company, when her son was diagnosed with Neurofibromatosis Type 2, or NF2. NF2 is a rare genetic disorder that results in the development of tumors throughout the nervous system. Dr. Henwood on the mission: “In our society, the people who are suffering with the disorder are often the ones left to figure out the cure. We’re left to cure ourselves. And that’s for every disorder, not just NF2. But why is that? Our mission is to change that. And we won’t give up.” As problem solvers who appreciate other problem solvers, we are proud to partner with Merlin Therapeutics and support NF2 Biosolutions. #rarediseaseday #CDMO #viralvectors #biotech #genetherapy #cellandgenetherapy #pharma #healthcare #precisionmedicine #raredisease #myhope4NF #myhope4NF2?

?? GENEZEN CARES ?? This week, our teams in Fishers, Indiana, and Lexington, Massachusetts, came together to show that we stand united in support of those affected by rare diseases. Rare Disease Day is tomorrow, February 28, and serves to raise visibility about rare diseases and their significant impact on individuals and families. It’s a time to advocate for research, improved diagnosis, and better treatment options while also showing support for the global rare disease community. #DYK ??5% of the world population is affected by rare diseases ??There are 6k+ identified rare diseases ??72% of rare diseases are genetic ??70% of genetic rare diseases start in childhood ??1 in 5 cancers is rare ??Equity means fair access to diagnosis, treatment, care and opportunities We invite you to join us in supporting #RareDiseaseDay by sharing your colors. Together, we can make a difference.?? ? #rarediseaseday #genetherapy #cellandgenetherapy #precisionmedicine #genezencares #rarediseasecommunity?#CDMO #viralvectors #biotech

?? BLACK HISTORY IN MEDICINE ?? In honor of Black History Month, we are highlighting key pioneers in medicine and biotech. In 1986, Marilyn Hughes Gaston published a groundbreaking study that led to the creation of a national sickle cell disease screening program for newborns and proved the effectiveness of penicillin in preventing infection from sepsis in babies with the disease. She became the first Black female physician to become director of the Bureau of Primary Health Care in the U.S. Health Resources and Services Administration. Gaston was also the second Black woman to serve as assistant surgeon general and achieve the rank of rear admiral in the U.S. Public Health Service. Today, gene therapy aims to cure sickle cell disease by modifying a patient's own blood stem cells, using genetic engineering techniques to correct the faulty gene responsible for producing abnormal hemoglobin, which causes red blood cells to sickle and leads to painful crises. This essentially allows the body to produce healthy red blood cells instead of sickle-shaped ones, potentially offering a long-term solution to the disease.? ? #viralvectors #CDMO #genetherapy #cellandgenetherapy #biotech #pharma #precisionmedicine #blackhistorymonth #blackexcellence #blackhistory

February 28 is Rare Disease Day ?? DID YOU KNOW? ?? 72% of rare diseases are genetic. Gene therapies can improve quality of life and long-term function.? What sets gene therapies apart? They can treat the root cause of a disease, rather than just treating symptoms. If you’re working on a gene therapy project, let’s talk: https://lnkd.in/emE_wKTw To learn more about Rare Disease Day, visit www.rarediseaseday.org #viralvectors #CDMO #genetherapy #cellandgenetherapy #biotech #pharma #precisionmedicine #rarediseaseday?

?? BLACK HISTORY IN MEDICINE ?? In honor of Black History Month, we are highlighting key pioneers in medicine and biotech. Charles Richard Drew was a physician, researcher, and surgeon who revolutionized our understanding of blood plasma. Drew's research on blood transfusions followed the discovery that human blood could be categorized into four main types (A, B, AB, O).? In 1938, he accepted a fellowship to continue his blood research at Columbia University. There, Drew developed a method for processing and storing blood plasma that allowed it to be dehydrated, shipped great distances, and then reconstituted just before transfusions. Drew became the director of the blood bank of the American Red Cross. He organized the largest blood drive ever, involving 100,000 donors, for the U.S. Army, and Navy. Drew was infuriated when the military ordered the Red Cross to label the blood with each donor's race and to refuse African American donors. He resigned as a result. Today, blood storage is important for cancer treatment because cancer and its treatments can damage blood cell production. Blood transfusions can help cancer patients by increasing their healthy blood cell count.?? #viralvectors #CDMO #genetherapy #cellandgenetherapy #biotech #pharma #precisionmedicine #blackhistorymonth #blackexcellence #blackhistory Photo Credit: Charles Richard Drew

?? INSIGHT ?? We conducted an exclusive industry survey on the challenges and opportunities in negotiating reimbursement for cell and gene therapies to help our partners and therapeutic innovators on their drug development journey. The results shed light on reimbursement models that are reshaping the CGT market, how companies are adapting development plans for success, and factors influencing investor confidence. Download the report here and schedule time to talk with us about how Genezen can help navigate CMC challenges as your CDMO partner: https://lnkd.in/efpEctDa? ?? #CDMO #viralvectors #genetherapy #cellandgenetherapy #biotech #pharma #precisionmedicine #payor?

?? LET'S MEET ?? Eric Weiss and Ka Ying Florence Lip will be in Boston for the Viral Vector Process Development Summit, and they're ready to talk with you about: ? Scalability ? Reproducibility ? Upstream Processing ? Downstream Processing ? Quality Control Contact them directly or click here to set a time: https://lnkd.in/ej5uSuAD #viralvectors #CDMO #biotech #genetherapy #cellandgenetherapy #raredisease #pharma #precisionmedicine

Please join us January 29 for an expert-led breakout session at 2pm EST during Genetic Engineering & Biotechnology News second annual State of Cell and Gene Therapy virtual summit! Susan D'Costa, Chief Technical and Commercial Officer at Genezen, will discuss efficiency and cost-effectiveness in lentiviral manufacturing. Register now: https://lnkd.in/gdFKvngK

Are you in Dallas for #AdvancedTherapiesWeek? If so, meet up with Megan Hardy and Zuelay E. Rosario, PhD to talk about your projects! #viralvectors #genetherapy #cellandgenetherapy #WIAT #precisionmedicine #pharma #biotech